Sema4D在川崎病血管内皮间质转化中的作用及机制OA
Role and mechanism of Sema4D in endothelial-to-mesenchymal transition in Kawasaki disease
目的 探讨信号素4D(Sema4D)在川崎病(KD)血管内皮间质转化(EndMT)中的作用及其分子机制.方法 为观察Sema4D对EndMT的作用,将人冠状动脉内皮细胞(HCAEC)分为HC组、KD组和KD+VX15/2503(为Sema4D中和抗体)组;HC组与KD组分别用20%健康儿童混合血清与20%KD患儿混合血清干预,KD+VX15/2503组用20%经VX15/2503预处理的KD患儿混合血清干预;采用RT-qPCR检测三组细胞EndMT的内皮标志物(CD31、VE-cadherin和ZO-1)与间质标志物(α-SMA和Vimentin)的mRNA表达.为探究PlexinB受体对Sema4D介导的EndMT的影响,将HCAEC分为KD组、KD+si-ctrl组、KD+si-PlexinB1组和KD+si-PlexinB2组,采用RT-qPCR检测EndMT标志物的mRNA表达.为分析Sema4D对NLRP3炎症小体和NF-κB的影响,将HCAEC分为KD组、rhSema4D组、rhSema4D+si-ctrl组、rhSema4D+si-PlexinB1组和rhSema4D+si-PlexinB2组,采用RT-qPCR检测NLRP3炎症小体相关基因(NLRP3、ASC、caspase-1、IL-1β和IL-18)mRNA表达,Western blot检测NF-κB p65磷酸化(p-p65)水平.为探究NLRP3对Sema4D介导的EndMT的影响,将HCAEC分为KD+si-ctrl组、KD+si-NLRP3组、rhSema4D+si-ctrl组和 rhSema4D+si-NLRP3组,采用 RT-qPCR 检测 EndMT标志物的 mRNA 表达.为验证 NF-κB通过激活 NLRP3介导EndMT,将HCAEC分为PBS组、BAY11-7082(NF-κB抑制剂)组、PBS+rhSema4D组和BAY11-7082+rhSema4D组及OE-ctrl+PBS组、OE-ctrl+rhSema4D 组、OE-ctrl+BAY11-7082+rhSema4D 组和 OE-NLRP3+BAY11-7082+rhSema4D 组,采用 RT-qPCR 检测EndMT标志物及NLRP3表达.结果 与HC组相比,KD组内皮标志物(CD31、VE-cadherin和ZO-1)降低、间质标志物(α-SMA和Vimentin)升高(均P<0.05);KD+VX15/2503组逆转上述变化(均P<0.05).与KD+si-ctrl组相比,KD+si-PlexinB2组CD31、VE-cadherin和ZO-1表达升高、α-SMA和Vimentin表达降低(均P<0.05),而KD+si-PlexinB1组各指标变化差异无统计学意义.与rhSema4D+si-ctrl组 相 比,rhSema4D+si-PlexinB2组NLRP3炎症小体相关基因表达及NF-κB p-p65水平均降低(P<0.05),rhSema4D+si-PlexinB1组各指标变化差异无统计学意义.与rhSema4D+si-ctrl组相比,rhSema4D+si-NLRP3组CD31、VE-cadherin和ZO-1表达增高、α-SMA和Vimentin表达下降(均P<0.05).与PBS+rhSema4D组相比,BAY11-7082+rhSema4D组CD31、VE-cadherin和ZO-1表达升高、α-SMA和Vimentin及NLRP3表达降低(均P<0.05).与OE-ctrl+BAY11-7082+rhSema4D组相比,OE-NLRP3+BAY11-7082+rhSema4D组CD31、VE-cadherin和ZO-1表达降低、α-SMA和Vimentin表达升高(均P<0.05).结论 Sema4D通过PlexinB2受体激活NF-κB/NLRP3信号轴,诱导冠状动脉内皮细胞发生EndMT.
Objective To investigate the role of Sema4D in endothelial-to-mesenchymal transition(EndMT)in Kawasaki disease(KD)and its underlying molecular mechanisms.Methods To observe the effect of Sema4D on EndMT,human coronary artery endo-thelial cells(HCAECs)were divided into HC group,KD group and KD+VX15/2503 group.The HC group was treated with 20%pooled serum from healthy children,the KD group was treated with 20%pooled serum from children with KD,and the KD+VX15/2503 group was treated with 20%pooled KD serum after pre-treatment with the Sema4D neutralizing antibody VX15/2503.RT-qPCR was performed to detect the mRNA expressions of endothelial markers(CD31,VE-cadherin,ZO-1)and mesenchymal markers(α-SMA,Vimentin)related to EndMT in cells.To investigate the role of PlexinB receptors in Sema4D-induced EndMT,HCAECs were divided into KD group,KD+si-ctrl group,KD+si-PlexinB1 group and KD+si-PlexinB2 group,and RT-qPCR was used to measure the mRNA expressions of EndMT markers.To analyze the regulatory effect of Sema4D on the NLRP3 inflammasome and NF-κB signaling,HCAECs were also divided into KD group,rhSema4D group,rhSema4D+si-ctrl group,rhSema4D+si-PlexinB1 group and rhSema4D+si-PlexinB2 group;RT-qPCR was used to detect the mRNA expressions of NLRP3 inflammasome-related genes(NLRP3,ASC,cas-pase-1,IL-1β and IL-18),and Western blot was used to assess NF-κB p65 phosphorylation(p-p65)level.To explore whether NLRP3 participates in Sema4D-mediated EndMT,HCAECs were divided into KD+si-ctrl group,KD+si-NLRP3 group,rhSema4D+si-ctrl group and rhSema4D+si-NLRP3 group;RT-qPCR was carried out to quantify the mRNA expressions of EndMT markers.To verify that NF-κB triggers EndMT by activating NLRP3,HCAECs were divided into two sets of groups:PBS group,BAY11-7082(inhibitor of NF-κB)group,PBS+rhSema4D group,BAY11-7082+rhSema4D group,and OE-ctrl+PBS group,OE-ctrl+rhSema4D group,OE-ctrl+BAY11-7082+rhSema4D group,OE-NLRP3+BAY11-7082+rhSema4D group;RT-qPCR was used to measure EndMT markers and NLRP3 expression.Results Compared with HC group,the KD group showed decreased expressions of endothelial markers(CD31,VE-cadherin and ZO-1)and increased expressions of mesenchymal markers(α-SMA and Vimentin,all P<0.05);these changes were reversed in KD+VX15/2503 group(P<0.05).Compared with KD+si-ctrl group,the KD+si-PlexinB2 group exhibited increased CD31,VE-cadherin and ZO-1 expressions,and decreased α-SMA and Vimentin expressions(all P<0.05),whereas no significant differences were observed in KD+si-PlexinB1 group.Compared with rhSema4D+si-ctrl group,the rhSema4D+si-PlexinB2 group showed reduced expressions of NLRP3 inflammasome-related genes and p-p65 level(P<0.05),while the rhSema4D+si-PlexinB1 group showed no sig-nificant differences.Compared with rhSema4D+si-ctrl group,the rhSema4D+si-NLRP3 group exhibited increased CD31,VE-cadherin and ZO-1 expressions,and decreased α-SMA and Vimentin expressions(P<0.05).Compared with PBS+rhSema4D group,the BAY11-7082+rhSema4D group showed increased expressions of CD31,VE-cadherin,and ZO-1,and decreased expressions of α-SMA,Vimentin and NLRP3(P<0.05).Compared with OE-ctrl+BAY11-7082+rhSema4D group,the OE-NLRP3+BAY11-7082+rh-Sema4D group exhibited decreased CD31,VE-cadherin and ZO-1 expressions,and increased α-SMA and vimentin expressions(P<0.05).Conclusion Sema4D induces EndMT in coronary artery endothelial cells by activating the NF-κB/NLRP3 signaling axis via its receptor PlexinB2.
黄君华;张书婉
西安医学院医学技术学院临床与血液学检验教研室,西安 710021西安市儿童医院检验科
医药卫生
川崎病血管内皮间质转化信号素4D神经丛素B2核因子κBNLRP3
Kawasaki diseaseendothelial-to-mesenchymal transitionsemaphorin 4DplexinB2NF-κBNLRP3
《山西医科大学学报》 2026 (8)
904-914,11
陕西省自然科学基础研究计划项目(2024JC-YBQN-0869)西安市科技计划项目(24YXYJ0064)西安市卫生健康委员会科研项目(2023qn12)
评论